GERALDINE SALALAC: Open Payments
NPI 1073004701 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$881 in 33 payments from 7 companies in 2025. Trend: 2023 $210 · 2024 $468 · 2025 $881
Food & beverage: $824Education: $57
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 18 | $471 |
| Regeneron Healthcare Solutions, Inc. | 7 | $203 |
| GlaxoSmithKline, LLC. | 3 | $67 |
| SANOFI-AVENTIS U.S. LLC | 1 | $57 |
| Optinose US, Inc. | 2 | $55 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
| Phadia US Inc. | 1 | $14 |
Products named: DUPIXENT, XHANCE, NUCALA, ImmunoCAP.
Industry payments across NV — which companies pay providers there.
